Home › NDC Lookup › Ingredients › Alogliptin And Metformin Hydrochloride
📦 NDC / package directory — not a drug information page

Alogliptin And Metformin Hydrochloride NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Alogliptin And Metformin Hydrochloride products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

15
Package NDCs
13
Products
13
Active listings
0
Discontinued
5
Labelers
2
Strengths
1
Dosage forms
3
With NADAC pricing

By strength, form & labeler

NDC products by strength
ALOGLIPTIN BENZOATE 12.5 mg/1; MET... 7
ALOGLIPTIN BENZOATE 12.5 mg/1; MET... 6
By dosage form
TABLET, FILM COATED 13
Top labelers
Padagis Israel Pharmaceuticals Ltd 4
Takeda Pharmaceuticals America, In... 4
Takeda GmbH 2
Takeda Pharmaceuticals Co LTD 2
A-S Medication Solutions 1

Browse records — 13 products

Drug / product Billing NDC NADAC / unit Status
alogliptin and metformin hydrochloride 12.5 mg/1; 1000 mg/1 TABLET, FILM COATED A-S · NDC 50090-5993-00 · 90 TABLET, FILM COATED in 1 BOTTLE (50090-5993-0) 50090-5993-00 — On market View →
alogliptin and metformin hydrochloride 12.5 mg/1; 1000 mg/1 TABLET, FILM COATED Takeda · NDC 47234-1251-01 · 14814 TABLET, FILM COATED in 1 DRUM (47234-1251-1) 47234-1251-01 — On market View →
alogliptin and metformin hydrochloride 12.5 mg/1; 1000 mg/1 TABLET, FILM COATED Padagis · NDC 45802-0211-72 · 60 TABLET, FILM COATED in 1 BOTTLE (45802-211-72) 45802-0211-72 $2.465 /unit · NADAC On market View →
alogliptin and metformin hydrochloride 12.5 mg/1; 500 mg/1 TABLET, FILM COATED Takeda · NDC 47234-1255-01 · 27397 TABLET, FILM COATED in 1 DRUM (47234-1255-1) 47234-1255-01 — On market View →
alogliptin and metformin hydrochloride 12.5 mg/1; 1000 mg/1 TABLET, FILM COATED Takeda · NDC 11532-1251-01 · 13000 TABLET, FILM COATED in 1 DRUM (11532-1251-1) 11532-1251-01 — On market View →
alogliptin and metformin hydrochloride 12.5 mg/1; 500 mg/1 TABLET, FILM COATED Takeda · NDC 11532-1255-01 · 26000 TABLET, FILM COATED in 1 DRUM (11532-1255-1) 11532-1255-01 — On market View →
alogliptin and metformin hydrochloride 12.5 mg/1; 500 mg/1 TABLET, FILM COATED Padagis · NDC 45802-0169-72 · 60 TABLET, FILM COATED in 1 BOTTLE (45802-169-72) 45802-0169-72 $2.321 /unit · NADAC On market View →
alogliptin and metformin hydrochloride 12.5 mg/1; 500 mg/1 TABLET, FILM COATED Padagis · NDC 45802-0169-72 · 60 TABLET, FILM COATED in 1 BOTTLE (45802-169-72) 45802-0169-72 $2.321 /unit · NADAC On market View →
alogliptin and metformin hydrochloride 12.5 mg/1; 1000 mg/1 TABLET, FILM COATED Padagis · NDC 45802-0211-72 · 60 TABLET, FILM COATED in 1 BOTTLE (45802-211-72) 45802-0211-72 $2.465 /unit · NADAC On market View →
KAZANO alogliptin and metformin hydrochloride 12.5 mg/1; 1000 mg/1 TABLET, FILM COATED Takeda · NDC 64764-0337-01 · 4 CARTON in 1 TRAY (64764-337-01) / 1 BLISTER PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 BLISTER PACK 64764-0337-01 — On market View →
KAZANO alogliptin and metformin hydrochloride 12.5 mg/1; 500 mg/1 TABLET, FILM COATED Takeda · NDC 64764-0335-01 · 4 CARTON in 1 TRAY (64764-335-01) / 1 BLISTER PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 BLISTER PACK 64764-0335-01 — On market View →
KAZANO alogliptin and metformin hydrochloride 12.5 mg/1; 500 mg/1 TABLET, FILM COATED Takeda · NDC 64764-0335-01 · 4 CARTON in 1 TRAY (64764-335-01) / 1 BLISTER PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 BLISTER PACK 64764-0335-01 — On market View →
KAZANO alogliptin and metformin hydrochloride 12.5 mg/1; 1000 mg/1 TABLET, FILM COATED Takeda · NDC 64764-0337-01 · 4 CARTON in 1 TRAY (64764-337-01) / 1 BLISTER PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 BLISTER PACK 64764-0337-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.